![Eske Rygaard-Hjalsted](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eske Rygaard-Hjalsted
Plus aucun poste en cours
Profil
Eske Rygaard-Hjalsted formerly worked at Intomics A, as Vice President-Sales & Business Development and Expres2ion Biotech Holding AB, as Vice President-Business Development from 2021 to 2022.
Mr. Rygaard-Hjalsted received his graduate degree from Delhi College of Engineering.
Anciens postes connus de Eske Rygaard-Hjalsted
Sociétés | Poste | Fin |
---|---|---|
EXPRES2ION BIOTECH HOLDING AB | Corporate Officer/Principal | 01/02/2022 |
Intomics A/S
![]() Intomics A/S Miscellaneous Commercial ServicesCommercial Services Intomics A/S provides data analysis solutions to data intensive research projectsa. Its services include advisory service, data analysis, and knowledge management. The firm helps clients in the pharmaceutical industry discover novel and drug targets, identify innovative and discriminative biomarkers, and enhance understanding of the underlying disease-biology at molecular level. The company was founded by Soren Brunak, Kasper Lage, Rasmus Wernersson and Thomas Skot Jensen in 2008 and is headquartered in Kongens Lyngby, Denmark. | Sales & Marketing | - |
Formation de Eske Rygaard-Hjalsted
Delhi College of Engineering | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
EXPRES2ION BIOTECH HOLDING AB | Health Technology |
Entreprise privées | 1 |
---|---|
Intomics A/S
![]() Intomics A/S Miscellaneous Commercial ServicesCommercial Services Intomics A/S provides data analysis solutions to data intensive research projectsa. Its services include advisory service, data analysis, and knowledge management. The firm helps clients in the pharmaceutical industry discover novel and drug targets, identify innovative and discriminative biomarkers, and enhance understanding of the underlying disease-biology at molecular level. The company was founded by Soren Brunak, Kasper Lage, Rasmus Wernersson and Thomas Skot Jensen in 2008 and is headquartered in Kongens Lyngby, Denmark. | Commercial Services |